# Fluvoxamine Maleate in the Treatment of Obsessive-Compulsive Disorder: A Post-marketing Clinical Study in Children and Adolescents

> **NCT00352768** · PHASE4 · TERMINATED · sponsor: **Solvay Pharmaceuticals** · enrollment: 20 (actual)

## Conditions studied

- Obsessive Compulsive Disorder

## Interventions

- **DRUG:** Fluvoxamine maleate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00352768
- **Lead sponsor:** Solvay Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-08
- **Primary completion:** 2009-04
- **Final completion:** 2009-04
- **Target enrollment:** 20 (ACTUAL)
- **Why stopped:** This study was prematurely terminated (26 June 2009) due to slow recruitment
- **Last updated:** 2010-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00352768

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00352768, "Fluvoxamine Maleate in the Treatment of Obsessive-Compulsive Disorder: A Post-marketing Clinical Study in Children and Adolescents". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00352768. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*